|
|
Consultants
of the Biologics Consulting Group, Inc. attend several conferences
every year during which they are available to provide company information
or consulting expertise. BCG consultants often participate in continuing
educational conferences and product/service focused seminars. Below
are some conferences that BCG consultants will be attending in the
near future, or have attended in the past. Please feel free to contact
the attending consultant either before, or during the conference
for company information or to discuss a business opportunity. Also,
please see our Presentations page to view
a copy of BCG conference presentations.
All documents are currently presented in Adobe Acrobat
"PDF" format. A current version of the Acrobat Reader
is required and may be found at Adobe's web site. To save a copy of the document
for yourself, click on the link with your right mouse button (Windows,
OS/2, Linux, and Solaris) or click and hold the single mouse button
(Mac) to display the context menu. Select "Save Link As...",
select the appropriate location (folder) and press "Save."
|
|
|
Date
of Conference |
Organization
sponsoring conference |
Conference
& Presentation Title |
BCG
Consultant(s) Attending |
Conference
Location |
| May
17-20, 2008 |
ISCT |
ISCT
14th Annual Meeting |
speakers
Ellen
M. Areman, MS, SBB
David
J. Pepperl, Ph.D. Darin
Weber, Ph.D. |
Miami,
FL |
| May
18 – 21, 2008 |
Society
for Clinical Trials |
29th
Annual Meeting |
Wilson
W. Bryan, MD |
St.
Louis, MO |
| May
19– 21, 2008 |
IBC
Life Sciences |
TIDES
2008: Oligonucleotide and Peptide Technology and Product Development
Conference Proven Strategies for Successful Drug and Diagnostic
Development
|
David
Lin, Ph.D. |
Las
Vegas, NV |
| June 5-6, 2008 |
FDLI |
Introduction to Biotechnology Law
and Regulation |
John
R. Godshalk, MSE, MBA
(speaker) |
Washington, DC |
| June
8-11, 2008 |
Preclinical
Training Institute |
Study
Directing: Principles and Practices
"Your
"other boss": How an FDA reviewer reads your reports" |
Melanie
Hartsough, Ph.D.
(speaker)
|
South
Lake Tahoe, CA |
| June
12-13, 2008 |
Center
for Business Intelligence (CBI) |
3rd
Annual Stability Programs: Impurity Control, Global Compliance,
Program Design and Stability Data Management for the Bio/Pharmaceutical
Industry
“Develop
Complex Stability Programs for Biologics”
|
David
Lin, Ph.D.
(speaker) |
Philadelphia,
PA |
| June
16-19, 2008 |
Seton
Hall Law School
|
Health
Care Compliance Certification Program
"Advertising
& Promotion of Medical Devices" |
Stuart
Portnoy, MD
(speaker)
|
Newark,
NJ |
| June
22-26, 2008 |
Drug
Information Association |
44th
Annual Meeting |
Annie
McElderry-Zurbay, RN, MSN, ND
Ron
Salerno, Ph.D. |
Boston,
MA |
| July
24-25, 2008 |
CASSS |
CMC
Strategy Forum |
Nadine
Ritter, Ph.D. |
Bethesda,
MD |
| Aug.
14, 2008 |
Cambridge
Healthtech Institute |
Clinical
Risk Management and Safety for Vaccines |
Julia
Barrett, M.D., MPH
(speaker |
Cambridge,
MA |
| Sept.
8-12, 2008 |
PDA/FDA |
2008
PDA/FDA Joint Regulatory Conference |
Nadine
Ritter, Ph.D. |
Washington,
DC |
| Sept.
14-17, 2008 |
Regulatory
Affairs Professional Society (RAPS) |
Annual
Conference & Exhibition
"Follow-on
Biologics, (Biosimilars)” (Subbarao)
|
Speakers
Nanda
Subbaro, Ph.D.
Kelly
Reich, MS
Holli
Vaughan, MS, RAC
|
Boston,
MA |
| Sept
28-Oct 4, 2008 |
|
ISO
TC 106 Dental Devices Annual Meeting |
Angela
Blackwell, MS |
Göteborg,
Sweden |
| October
4-7, 2008 |
AABB
(American Association of Blood Banks) |
Annual
Meeting and TXPO |
Ellen
M. Areman, MS, SBB
(session
chair) |
Montreal,
Canada |
| November
9-12, 2008 |
ACT
(American College of Toxicology) |
29th
Annual Meeting |
John
Jessop, Ph.D., MPH
David
J. Pepperl, Ph.D. |
Tuscon, AZ |
| Nov
18-21, 2008 |
ASTM
|
November
Meeting week Division IV Tissue Engineered Medical Products
|
Angela
Blackwell, MS |
Miami
Beach, FL |
|
Past
Conferences Attended... |
| May
8-10, 2008 |
UCSC
Extension in Silicon Valley |
Special
Regulatory Programs - click below to sign up for either
course presented by BCG at UCSC
"FDA
Regulation of Biotechnology and Biologics Products: From IND
to BLA"
"Medical
Devices and the FDA: An Insider's Perspective" |
Jim
Kenimer,Ph.D.
Ron
Marchesani
Janice
Wilson, Ph.D.
Carl
Anderson
Susan
Bowley, Ph.D.
Stuart
Portnoy, M.D. |
University
of California Extension, Santa Cruz |
| May
6-9, 2008 |
ASTM
International |
Committee
Week
Division
IV Tissue Engineered Medical Products
Medical
and Surgical Materials and Devices |
Angela
Blackwell, MS
Susan
M. Bowley, Ph.D.
|
Denver,
CO |
| May
6, 2008 |
FDA
& Industry Conference |
Creating
New Knowledge, FDA & Industry in dialogue |
Michael
Trapani, MS, MBA |
Philadelphia,
PA |
| April
29-May 2, 2008 |
Institute
of Validation Technology (IVT) |
Lab
Compliance
“Stability
Testing Fundamentals and Considerations in the Current Regulatory
Environment” |
David
T. Lin, Ph.D.
(speaker) |
Baltimore,
MD |
| April
29, 2008 |
ComplianceOnline |
GLP
Compliance Audits: What to look out for at a New Nonclinical
CRO |
David
J. Pepperl, Ph.D.
(speaker) |
on-line
seminar |
| April
28 - May 2, 2008 |
Cambridge
Healthtech Institute |
4th
Annual PEGS (Protein Engineering Summit)
"Implementation
of a flexible cGMP complaint Stability Program for Phase I,
II and III Studies" |
Nanda
Subbaro, Ph.D.
(speaker)
|
Boston,
MA |
| April
24-25, 2008 |
International
Pharmaceutical Academy, Canada |
Developing
an Effective
Complaint Handling and Recalls Program |
Janice
Wilson, Ph.D.
(speaker) |
Toronto,
Canada |
| April
20-25, 2008 |
Society
of Quality Assurance (SQA) |
24th
SQA Annual Meeting and Training |
Carl
Anderson
(speaker)
Michael
Trapani, MS, MBA (speaker) |
Memphis,
TN |
| April
17, 2008 |
North
Carolina Biotechnology Center's Bioprocessing and Process Development
Group |
BioProcessing
& Process Development Intellectual Exchange Group
"Immune
Response to Protein Therapeutics" |
Nanda
Subbaro, Ph.D.
(speaker)
|
Research
Triangle Park, NC |
| April
14-18, 2008 |
PDA
|
2008
Annual Meeting
"Critical
Issues in the Vaccine Industry: A Review of Recent FDA Warning
Letters" (Wilson) |
Nadine
Ritter, Ph.D.
Janice
Wilson, Ph.D.
(speaker) |
Colorado
Springs, CO |
April
12 – 19, 2008
|
American
Academy of Neurology |
60th
Annual Meeting |
Wilson
W. Bryan, MD |
Chicago,
IL |
| April
7-9, 2008 |
CASSS |
European
CMC Strategy Forum |
Nadine
Ritter, Ph.D. |
Paris
France |
| April
3-5, 2008 |
AADR
American Associate for Dental Research |
Annual
Meeting |
Angela
Blackwell, MS |
Dallas,
TX |
| April
3, 2008 |
ComplianceOnline |
FDA
Expectations for Cell, Tissue and Gene Therapy Products |
David
J. Pepperl, Ph.D.
(speaker) |
on-line
seminar |
| March
28-29, 2008 |
AABB
(American Association of Blood Banks) |
Spring
Conference 2008
Regulatory
Considerations of Using Stem Cells for Cardiac Applications
|
Ellen
M. Areman, MS, SBB
(speaker) |
Orlando,
FL |
| March
26-28, 2008 |
Reed
Life Sciences
|
PharmaMedDevice
Conference
"Combination
Products -- Regulatory: Applications & Documentation"
|
Stuart
Portnoy, MD
(speaker) |
Philadelphia,
PA
|
| March
26-28, 2008 |
Regulatory
Affairs Professional Society (RAPS) |
2008
Horizons Conference |
Ron
Marchesani
(speaker)
Janice
Wilson, Ph.D. |
San
Francisco, CA |
| March
18-19, 2008 |
British
Columbia Institute of Technology (BCIT) |
Design
and Implementation of Effective Stability Studies for Biotechnology
Products |
Nadine
Ritter, Ph.D.
(course director) |
Vancouver,
BC, Canada |
| March
16-20, 2008 |
Society
of Toxicology |
SOT
Annual Meeting and Tox Expo |
John
Jessop, Ph.D., MPH |
Seattle,
WA |
| March
13, 2008 |
ComplianceOnline |
Utilizing
ICH Guidelines for GCP Regulatory Compliance |
Carl
Anderson
(speaker) |
on-line
seminar |
| March
10-11, 2008 |
IBC
Life Sciences Training Academy |
Process
Validation for Biologicals Conference |
Ron
Marchesani |
San
Diego, CA |
| March
6-7, 2008 |
ASENT
(American Society of Experimental NeuroTherapeutics) |
Annual
Meeting |
Wilson
W. Bryan, MD
(course co-director) |
Washington,
DC |
| March
2-4, 2008 |
The
Barnett Institute |
Biogenerics
2008 |
Nanda
Subbaro, Ph.D. |
Boston,
MA |
| February
25-29, 2008 |
Seton
Hall Law School
|
Health
Care Compliance Certification Program
"Advertising
& Promotion of Medical Devices" |
Stuart
Portnoy, MD
(speaker)
|
Newark,
NJ |
| February
21-22, 2008 |
Texas
Scottish Rite Hospital for Children |
30th
Annual Carrell-Krusen Neuromuscular Symposium |
Wilson
W. Bryan, M.D. |
Dallas,
TX |
| February
12-15, 2008 |
R&D
Directions |
5th
Annual Drug Development Summit 2008 |
David
T. Lin, Ph.D.
(speaker) |
Amelia
Island, FL |
| February
11-13, 2008 |
Pharmaceutical
Education and Research Institute (PERI), Inc. |
Effective
Planning & Management of Clinical Trials |
Wilson
W. Bryan, M.D.
(course co-director) |
Arlington,
VA |
| February
9-10, 2008 |
ISCTR
(International Society for Cardiovascular Translational Research) |
Annual
Meeting
"Regulatory
Considerations for Cell Manufacturing and Cell Delivery" |
Darin
Weber, Ph.D.
(speaker) |
San
Diego, CA |
| February
9-10, 2008 |
DIA
(Drug Information Association) |
21st
Annual DIA Conference for Electronic Document Management: Managing
Documents and Records |
Dan
Offringa
Kelly
Reich, MS
Holli
Vaughan, MS, RAC |
Philadelphia,
PA |
| January
28-30, 2008 |
Phacilitate |
Phacilitate
Cell & Gene Therapy Forum 2008 |
Andra
Miller, Ph.D.
Maritza
C. McIntyte, Ph.D.
Darin
Weber, Ph.D.
|
Washington
DC |
| January
28-29, 2008 |
International
Pharamceutical Academy (IPA) |
FDA
Pre-Approval Inspections
"FDA
approval processes and combination device and biologics inspections" |
John
R. Godshalk, MSE, MBA
(speaker) |
Toronto,
Canada |
| January
27-30, 2008 |
CASSS |
CMC
Strategy Forum
12th
Annual Symposium on the Interface of Regulatory and Analytical
Sciences for Biotechnology Health Products |
Nadine
Ritter, Ph.D.
(speaker)
Keith
Wells, Ph.D.
Ruth Wolff, Ph.D.
|
Washington, DC |
| January
27-30, 2008 |
CASSS |
CMC
Strategy Forum
Extractables
and Leachables: Challenges and Strategies in Biopharmaceutical
Development |
Keith
Wells, Ph.D.
Ruth Wolff, Ph.D.
|
Washington, DC |
| January
27-30, 2008 |
CASSS |
CMC
Strategy Forum
Current
Practices for Assessing the Comparability and Stability of
Gene Therapy Products |
Andra
Miller, Ph.D.
Maritza
C. McIntyte, Ph.D.
Nadine
Ritter, Ph.D.
(co-leader)
Darin
Weber, Ph.D.
|
Washington, DC |
| January
21-23, 2008 |
Institute
for International Research |
5th
Annual Formulation & Forced Degradation
"Implementation
of a flexible yet cGMP complaint Stability Program for Phase
I, II and III Studies" |
Nanda
Subbaro, Ph.D.
(speaker) |
San
Diego, CA |
| January
17 - 18, 2008 |
IBC
China |
US
FDA Biological Approval Process |
Lei
Zhang, MD, Ph.D.
(speaker) |
Taipei,
Taiwan |
| January
14 - 16, 2008 |
ALS
Association |
ALSA
Research Workshop |
Wilson
W. Bryan, M.D.
(speaker)
|
Tampa,
FL |
| January
14 - 15, 2008 |
IBC
China |
US
FDA Biological Approval Process |
Lei
Zhang, MD, Ph.D.
(speaker) |
Seoul,
South Korea |
| December
20, 2007 |
Pennsylvania
BIO & Nanotechnology
Institute & Ben
Franklin Technology Partners |
Overcoming
Barriers Faced When Bringing a Bio-Nanotechnology Product to
Market
|
Stuart
Portnoy, MD
|
Philadelphia,
PA |
| December
13 - 14, 2007 |
IBC
China |
US
FDA Biological Approval Process |
Lei
Zhang, MD, Ph.D.
(speaker) |
Beijing,
China |
| December
7 - 11, 2007 |
American
Society of Hematology |
49th
Annual Meeting and Exposition |
Liana
Harvath, Ph.D. |
Atlanta,
GA |
| November
12-15, 2007 |
AAPS
(American Association of Pharmaceutical Scientists) |
AAPS
Annual Meeting
“Critical
Stability Evaluation of Biopharmaceuticals During Clinical
Development” |
David
T. Lin, Ph.D.
(speaker) |
San
Diego, CA |
| November
12-14, 2007 |
ACT
(American College of Toxicology) |
Annual
Meeting |
Melanie
Hartsough, Ph.D.
John
Jessop, Ph.D., MPH
David
J. Pepperl, Ph.D. |
Charlotte, NC |
| November
12-13, 2007 |
Pharma
Conference |
Current
GMP Concepts: Focus on Biologics |
Eugene
Johnston, CQE, CQA |
San
Antonio, TX |
| November
8-9, 2007 |
FDA-HHS-NIAID
workshop |
Anthrax
Vaccines- Bridging Correlates of Protection in Animals and Immunogenicity
in Humans |
Ann
Sutton |
Gaithersburg,
MD |
| November
5-7, 2007 |
Informa
Life Sciences
|
Medical
Device Regulations: Essential Training in Present and Pending
Medical Device Regulations
"Introduction
to US FDA Regulations"
|
Stuart
Portnoy, MD
(speaker)
|
Munich,
Germany
|
| October
23, 2007 |
Second
Annual FDA Inspections Summit |
Getting
it Right the First Time, Every Time
"Combination
and Device Inspections" Godshalk
"Essential
Documents: Auditing Trial Master Files" Anderson |
John
R. Godshalk, MSE, MBA
(speaker)
Carl
Anderson
(speaker) |
Bethesda, MD |
| October
20 - 23, 2007 |
AABB
(American Association of Blood Banks) |
Annual
Meeting & TXPO 2007
“New
Technologies in Cellular Product Testing” |
Ellen
M. Areman, MS, SBB
(moderator) |
Anaheim,
CA |
| October
8 - 9, 2007 |
BioNJ
and Pennsylvania Bio |
Biotech
2007 |
Joe
Clancy - BCG Board of Directors
Michael
Trapani, MS, MBA
Keith
Wells, Ph.D. |
Philadelphia,
PA |
| October
2 - 3, 2007 |
|
2007
International Symposium on Regulation of Human Cell and Tissue-Based
Products
"FDA
Regulations and Practices for Human Cell and Tissue-Based
Therapies/Products"
"Biosafety and Manufacturing Considerations for Clinically
Cell-Based Therapies" |
Darin
Weber, Ph.D.
(speaker) |
Taipei,
Taiwan |
| October
2 - 3, 2007 |
IVT
Lab Week |
Capturing
the Science of Stability Testing
"Out-of
-Specification Investigations for Stability Samples" |
Nanda
Subbaro, Ph.D.
(speaker) |
San
Diego, CA |
| September
26, - 28, 2007 |
ISCT |
Somatic
Cell Therapy Symposium
“Use
of Devices in Cell Therapy Manufacturing” |
Ellen
M. Areman, MS, SBB
(session
moderator)
Liana
Harvath, Ph.D.
(session moderator)
|
Bethesda,
MD |
| September
23- 26, 2007 |
Regulatory
Affairs Professional Society (RAPS) |
Annual
Conference & Exhibition
"Regulatory
Considerations for Starting a Gene Therapy Trial in the US"
(Miller)
"Facility
Design Considerations for Biologics" (Godshalk)
"Addressing
Immunogenicity of Biotechnology-Derived Therapeutic Products:
Preclinical, Clinical and Analytical Considerations"
(Subbarao)
"Quality
Expectations for Product Development CMC Activities: R&D,
GLP or GMP" (Weber) |
Speakers
Andra
Miller, Ph.D.
John
R. Godshalk, MSE, MBA
Nanda
Subbaro, Ph.D.
Darin
Weber, Ph.D.
John
Jessop, Ph.D., MPH
Ron
Marchesani
Reggie
Neal
Kelly
Reich, MS
Holli
Vaughan, MS, RAC
Keith
Wells, Ph.D.
|
Boston,
MA |
| September
17 - 21, 2007 |
University
of Wisconsin-Madison |
10th
Annual Land O'Lakes Conference on Drug Metabolism/Applied Pharmacokinetics |
Melanie
Hartsough, Ph.D.
(speaker) |
Merrimac,
WI |
| September
10 - 12, 2007 |
AAPS
(Amercian Association of Pharmaceutical Scientists) |
AAPS
Workshop on Stability: Developing a Stability Program for
the Global Market
Stability
Challenges of OTCs, Nutraceuticals and Combination Products |
Nanda
Subbaro, Ph.D.
(moderator) |
North
Bethesda, MD |
| August
21 - 24, 2007 |
Cambridge
Healthtech Institute |
Target
Immunotherapeutics and Vaccine Summit
"Selecting
a Study Population" |
Stephen
Litwin, MD
(speaker) |
Cambridge,
MA |
| June
27 - 28, 2007 |
Pharmaceutical
Training Institute |
“Design
and Implement Effective Stability Programmes for Biotechnology
Products” |
Nadine
Ritter, Ph.D.
(speaker) |
London,
England |
| June
19 - 20, 2007 |
IVT
Method Validation Conference |
"Test
Method Qualification or Test Method Validation: What is the
Difference?" |
Nadine
Ritter, Ph.D.
(speaker) |
Brussels, Belgium |
| June
18 - 20, 2007 |
BIO
|
VentureForum
East 2007 |
Wilson
W. Bryan, M.D.
(speaker) |
Montreal,
Canada |
| June
18-21, 2007 |
Drug
Information Association (DIA) |
43rd
Annual Meeting
“The
Impact of FDA's Quality-by-design Initiative on Biologics
Development” |
David
T. Lin, Ph.D.
(speaker) |
Atlanta,
GA |
| June
17 - 23, 2007 |
|
Options
for Control of Influenza VI |
Mike
Williams |
Toronto,
Canada |
June
12 - 13, 2007
|
IBC
Life Sciences Training Academy |
"Best
Practices for Biotechnology Product Comparability and Stability
Studies -
Protocols, Test Methods and Quality Practices" |
Nadine
Ritter, Ph.D.
(speaker) |
Seattle,
WA |
| May
30 - Jun 3, 2007 |
ASGT
(American Society of Gene Therapy) |
10th
Annual Meeting |
Maritza
C. McIntyte, Ph.D.
(speaker)
|
Seattle,
WA |
| May
21 - 22, 2007 |
IVT
Method Validation Conference |
"Test
Method Qualification or Test Method Validation: What is the
Difference?" |
Nadine
Ritter, Ph.D.
(speaker) |
Boston, MA |
| May
15 - 16, 2007 |
IBC
Life Sciences Training Academy |
"Best
Practices for Biotechnology Product Comparability and Stability
Studies -
Protocols, Test Methods and Quality Practices" |
Nadine
Ritter, Ph.D.
(speaker)
|
Boston,
MA |
| May
7 - 9, 2007 |
Pharmaceutical
Education Research Institute (PERI) |
Effective
Planning and Management of Clinical Trials |
Wilson
W. Bryan, M.D.
(Course
Co-Director ) |
Arlington,
VA |
| May
6 - 9, 2007 |
BIO
(Biotechnology Industry Organization) |
BIO
2007 (Booth #2281) |
Jim Kenimer, Ph.D.
& Others |
Boston,
MA |
| Apr.
28 - May 5, 2007 |
American
Academy of Neurology |
59th
Annual Meeting |
Wilson
W. Bryan, M.D. |
Boston,
MA |
| Apr.
23 - 27, 2007 |
BioProcess
International European Conference |
"Workshop
on Stability Testing For Biological Drugs" and "Workshop
on Managing CMC Changes from a Regulatory Perspective"
|
Nadine
Ritter, Ph.D.
(speaker) |
Paris,
France |
| Apr.
11 - 12, 2007 |
IBC
Life Sciences Training Academy |
"Best
Practices for Biotechnology Product Comparability and Stability
Studies -
Protocols, Test Methods and Quality Practices" |
Nadine
Ritter, Ph.D.
(speaker) |
San
Diego, CA |
| Mar.
28 - 30, 2007 |
Regulatory
Affairs Professional Society (RAPS) |
RAPS
2007 Horizons Conference & Exhibition |
Sarah
McNulty, RAC |
San
Francisco, CA |
| March
25-28, 2007 |
Society
of Toxicology |
SOT
Annual Meeting |
John
Jessop, Ph.D.
David
Pepperl, Ph.D.
Tanya
Kersten, Ph.D. |
Charlotte,
NC |
| Mar.
23-27, 2007 |
AABB
|
Spring
Cell Therapy Conference
Moderating
session on Novel Cell Therapies |
Ellen
M. Areman, MS, SBB
John
R. Godshalk, MSE, MBA
(speakers) |
San
Diego, CA |
| Mar.
19 - 22, 2007 |
Terapinn |
World
Vaccine Congress 2007
Agenda |
Peter
Patriarca, M.D.
(chairman)
Julia
Barrett, M.D., MPH
David
Pepperl, Ph.D.
Nadine
Ritter, Ph.D.
Keith
Wells, Ph.D.
(speakers) |
Washington,
DC |
| March
19-21, 2007 |
Institute
for International Research (IIR) |
Formulation
and Forced Degradation Strategies for Biomolecules
“Regulatory
Requirements for Successful Product Development”
|
David
T. Lin, Ph.D.
(speaker) |
San
Diego, CA |
| Mar.
14 - 17, 2007 |
Mayo
Clinic |
Oncolytic
Virus Conference |
Maritza
C. McIntyte, Ph.D.
(speaker) |
Carefree,
AZ |
| Mar.
14 - 15, 2007 |
Pharmaceutical
Training Institute |
“Design
and Implement Effective Stability Programmes for Biotechnology
Products” |
Nadine
Ritter, Ph.D.
(speaker) |
London,
England |
| |
